Choriogonadotropin Alfa — Drug Intelligence | 9 EU Trials

Filter these 9 trials by condition, phase, country and more.

Open in Search →

9 Registered trials

7 Recruiting

1 Completed trials

8 Sponsors

5 Countries

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 2 Phase II: 2 Phase III/IV: 1 Phase IV: 4

Indications tested

Assisted reproductive technology 1 Infertility 1 Breast cancer 1

Sponsors using this IMP

Santiago Dexeus Font Fundacio Privada 2 Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Intercommunal Creteil 1 Ferring Pharmaceuticals A/S 1 Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer 1 Institut De Cancerologie De L Ouest 1 Rigshospitalet 1 Universitair Ziekenhuis Gent 1

All trials

9 total

MENOPUR and REKOVELLE in Women UnderGoing an assisted reproductive technology cycle Pending

2022-500308-23-00 Phase III/IV 2 countries Ferring Pharmaceuticals A/S
An RCT investigating hCG priming in women with diminished ovarian reserve Recruiting

2025-521234-28-00 Phase III 1 country Rigshospitalet
Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer (PRESAGE) Recruiting

2024-516282-37-00 Phase II 1 country Institut De Cancerologie De L Ouest
Using a fixed dosage of follitropin delta for ovarian stimulation for intrauterine insemination. Recruiting

2025-520681-22-00 Phase II 1 country Centre Hospitalier Intercommunal Creteil
Impact of the presence of the corpus luteum on pregnancies obtained through frozen embryo transfer(FET): a prospective randomizedcontrolled … Recruiting

2024-513600-33-00 Phase IV 1 country Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
PErsonalized Addition of Recombinant LH in suboptimal responders >35 years old (POSEIDON group 2). A randomized controlled trial Recruiting

2024-514035-19-00 Phase IV 1 country Santiago Dexeus Font Fundacio Privada
Ovulation induction and luteal phase support with GnRH agonists in in vitro fertilization Recruiting

2023-505126-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A randomized comparison of one controlled ovarian stimulation with corifollitropin alfa (CFA) versus up to three modified natural cycles (MN… Recruiting

2023-509094-23-00 Phase IV 1 country Universitair Ziekenhuis Gent
The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial. Ended

2024-514322-23-00 Phase IV 1 country Santiago Dexeus Font Fundacio Privada

Showing 1–9 of 9 trials

← All drugs A–Z